A Study to Investigate the Absolute Bioavailability, Absorption, Metabolism, Distribution and Excretion of [14C]AZD5363 (Capivasertib)

NCT05419401 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

7

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteer

Interventions

DRUG: Capivasertib film-coated tablet, 200 mg
DRUG: [14C]AZD5363 (Capivasertib)

Sponsor

AstraZeneca

Collaborators

[object Object]